Olaparib inhibits PARP1 and PARP2 enzymes, leading to unrepaired DNA single-strand breaks and double-strand breaks during cell division, causing synthetic lethality in tumor cells with homologous recombination repair deficiencies. https://medsforcancer.com/product/olanib50-150mg-olaparib/